- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 47.11M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 46.98M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 38.72M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $87K |
| Capex | Q1 2026 · Mar 31, 2025 | $1.26M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$18.11M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$13.89M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $36.18M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $29.84M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $76.51M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $282.14M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $295.73M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $316.39M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $330.04M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $49.91M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $74.76M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $84.53M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $123.04M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $185.73M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $212.26M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $366.67M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $418.77M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.37 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.53 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.37 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.53 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $29.77M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $31.17M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $7.32M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $10.04M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$17.54M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$20.5M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$41.36M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$26.37M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $15.57M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $14.84M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $20.85M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $15.5M |
| Revenue | Q1 2026 · Mar 31, 2026 | $36.42M |
| Revenue | Q1 2026 · Mar 31, 2025 | $30.33M |